Investors

Financials & Filings

Document Details

Form
Filing Date
Mar 19, 2015
Document Date
Mar 17, 2015
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals